Key result
Adding lipid-lowering therapy to antihypertensive regimens is linked to ~30 mg/dL lower mean LDL-C.
Why the study?
Hypertension is frequently associated with dyslipidemia, which increases the risk of atherosclerotic cardiovascular disease, but the relationship between lipid abnormalities and hypertension in a hospital-based population needed evaluation.
Does combination therapy with lipid-lowering drugs improve lipid profiles compared to antihypertensive therapy alone in patients with hypertension?
Observational (n=50)
No
Does combination therapy with lipid-lowering drugs improve lipid profiles compared to antihypertensive therapy alone in patients with hypertension?
Absolute Event Rate: 115% vs 145%
p-value: p=<0.01
Dyslipidemia is highly prevalent in hypertensive patients and correlates with poor blood pressure control, suggesting that integrated management with lipid-lowering therapy significantly improves lipid parameters.
Combination therapy was associated with better lipids in hypertensives; hypothesis-generating and should not yet change practice.
Background:Hypertension is a major cardiovascular risk factor frequently associated with dyslipidemia, which further increases the risk of atherosclerotic cardiovascular disease. Abnormal lipid profiles among hypertensive patients contribute significantly to morbidity and mortality. This study aimed to evaluate the relationship between lipid profile abnormalities and hypertension in a hospital-based population.Methodology:This retrospective descriptive study was conducted in the Department of General Medicine at Sree Mookambika Institute of Medical Sciences from March 2025 to February 2026. A total of 50 hypertensive patients were included in the study. Data regarding demographic details, blood pressure measurements, medication history, and lipid profile parameters were collected from electronic health records. Statistical analysis was performed using SPSS version 25.0. Correlation analysis, Student’s t-test, and ANOVA were used where appropriate, with p <0.05 considered statistically significantResults: The study included 25 males and 25 females with a mean age of 62 ± 8 years. Elevated LDL cholesterol was observed in 46% of patients, low HDL cholesterol in 54%, and elevated triglycerides in 38%. Uncontrolled hypertension showed significant positive correlation with LDL cholesterol (r=0.34, p<0.05) and negative correlation with HDL cholesterol (r=-0.29, p<0.05). Patients on combination therapy demonstrated significantly improved lipid parameters.Conclusion:Dyslipidemiawas highly prevalent among hypertensive patients and was significantly associated with poor blood pressure control. Integrated management of hypertension and lipid abnormalities may help reduce cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
T et al. (2026) conducted an observational in Hypertension (n=50). Combination of antihypertensive and lipid-lowering therapy vs. Antihypertensive therapy alone was evaluated on Mean LDL cholesterol (mg/dL) (p=<0.01). Patients receiving combination antihypertensive and lipid-lowering therapy exhibited significantly lower mean LDL cholesterol (115 mg/dL vs 145 mg/dL) and higher HDL cholesterol than those on antihypertensive therapy alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: